{"id":886707,"date":"2025-09-16T11:35:41","date_gmt":"2025-09-16T15:35:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/"},"modified":"2025-09-16T11:35:41","modified_gmt":"2025-09-16T15:35:41","slug":"dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/","title":{"rendered":"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th"},"content":{"rendered":"<h2>\nDermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>SAN DIEGO, Sept.  16, 2025  (GLOBE NEWSWIRE) &#8212; <strong>Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18<\/strong><sup><strong>th<\/strong><\/sup><\/p>\n<p>\n        <strong><br \/>\n          <em>Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>San Diego, CA,\u00a0September 16, 2025\u00a0&#8212;\u00a0Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (\u201cDermata\u201d or the \u201cCompany\u201d), a science-driven leader in dermatologic solutions, today announced\u00a0that Gerry Proehl, Founder and CEO of Dermata, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025.<\/p>\n<p>\n        <strong>DATE<\/strong>: September 18<sup>th<\/sup><br \/><strong>TIME: 11:30 AM EST<\/strong><br \/><strong>LINK:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vmQV_OmZ8qf8Qvqh-gBnfziXP1P8NW474ZkedXJAf3G0lITx8_JrtOdS4XfTJd-14y4sUnElUGeIZ1Vnt7Lno5CuI0O7YnfCWJSQq49Yyi0x4cjNaCcTVwLhkNP0K4XQcL7vOh92NVtyMk4KZKQRBLtyUZ9cdsE4DkUPOJBY78QomUWAVcBTeCfBpauXGheW3ELF36nGqNV0bFpdlxXhD5PHEzrC8eIbE103RkfmgmSV2ijhOyacs9Wn2x6ZntCkp3wZQkDtVyJ6DJ3JVGdAX_H4rycr2zLLC7ci2ZS2MrY=\" rel=\"nofollow\" target=\"_blank\">REGISTER HERE<\/a><br \/><strong>Available for 1&#215;1 meetings:<\/strong> September 16-26th. Sign up <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7_8akRNHBA91KyLwWX9x2JQ1DkjX7pvZ8BIdAieg6cJPYYxFQ1nTZEH-oRmSQKFnispbL7_dgDJNIIpdyOiW8BcKl_YoKkaTVKdt1yGcO0YHIRyVLs1F6-ZrM4smTjpWZKg0TMXzqbgpxpkG_TobWMEuiSMeIkXEtWWc5LXCUlNpgpbqzsos-A1pgjcTLjb0VRpkMx_1B_iAWrsmfkWU8-t8ua8-BADOXvwEfqktnQslmvBxyJ6gRuR9JPLK7RHjBGr3BSd6CXcPLaqg9_slQ==\" rel=\"nofollow\" target=\"_blank\">here<\/a><\/p>\n<p>This will be a live, interactive online event where investors are invited to ask the Company<br \/>questions in real-time. If attendees are not able to join the event live on the day of the<br \/>conference, an archived webcast will also be made available after the event.<\/p>\n<p>It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.\u00a0\u00a0<\/p>\n<p>Learn more about the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QbIkbE5L3-3FLPdLFnfw0WMwuz-1kOXduXa0ANWvt4CDFDLCTBB0uJLztcf9_WDvVGz_JZVWyaM2gmCAjKOs4X7vVuFaOFbBi3FelNKQPsmiawBbfKUHW_oyycwM2AzPKyDrBu9W-GyaeAse2h1I3g==\" rel=\"nofollow\" target=\"_blank\"><u>www.virtualinvestorconferences.com<\/u><\/a><u>.<\/u><\/p>\n<p>\n        <strong>Recent Company Highlights<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Dermata recently announced a strategic pivot to over-the-counter skin care treatments<\/li>\n<li style=\"text-align:justify\">The pivot is designed to address a growing demand for high-quality, scientifically proven OTC products<\/li>\n<li style=\"text-align:justify\">The Company plans to launch its once-weekly OTC acne kit in the middle of 2026 which it believes is highly differentiated from current acne treatments\n<\/li>\n<\/ul>\n<p>\n        <strong>About Virtual Investor Conferences\u00ae<\/strong><br \/>\n        <br \/>Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.<\/p>\n<p>Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.\u00a0 Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking <\/strong><br \/>\n        <strong>Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are based on the Company&#8217;s current beliefs and expectations and new risks may emerge from time to time. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors including, but are not limited to, statements related to: Dermata\u2019s shift to prioritize OTC dermatology products; the anticipated benefits of the strategic shift; the anticipated benefits of Dermata\u2019s strategic shift, including acceleration of its path to commercialization, reduction of regulatory burdens, and expansion into broader consumer markets; the expected timing and success of any planned or future OTC product launches; and other factors described in the Company\u2019s filings with the Securities and Exchange Commission. These forward-looking statements are generally identified by the use of such words as \u201cmay,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201cbelieve,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201ccontinue,\u201d \u201coutlook,\u201d \u201cwill,\u201d \u201cpotential\u201d and similar statements of a future or forward-looking nature. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug development, approval and commercialization, and the fact that past results of clinical trials may not be indicative of future trial results. For a discussion of these and other factors, please refer to Dermata&#8217;s filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are qualified in their entirety by this cautionary statement and Dermata undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof, except as required by law.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Dermata Investors:<\/strong>\n      <\/p>\n<p align=\"justify\">Cliff Mastricola<br \/>Investor Relations<br \/>cmastricola@dermatarx.com<\/p>\n<p>\n        <strong>Virtual Investor Conferences <\/strong><br \/>\n        <br \/>John M. Viglotti<br \/>SVP Corporate Services, Investor Access<br \/>OTC Markets Group <br \/>(212) 220-2221<br \/>johnv@otcmarkets.com<\/p>\n<p align=\"justify\">Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (\u201cDermata\u201d or the \u201cCompany\u201d), a science-driven leader in dermatologic solutions, today announced\u00a0that Gerry Proehl, Founder and CEO of Dermata, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025.<\/p>\n<p align=\"justify\">\n        <strong>DATE<\/strong>: September 18<sup>th<\/sup><br \/><strong>TIME: 11:30 AM EST<\/strong><br \/><strong>LINK:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vmQV_OmZ8qf8Qvqh-gBnf0zJmXsqKACrdsDSE_mrlXZIOeQKGDGMvhQf3qq7UQ_3Nbq10mYHG9QIx1m2DKMHwKAOtykwbtYAVfT-o20B1wSCGOiWTzG_x0JhGRtcqwYE00FUECr5nKxW3c-JiKvmIGC9tY3M3ccdo-1ysaSJXlVmAupQgVmMNJmZNUciQaDM__XnWTWpxHgTGnifCFzzrjexipdIUYM7R6nv6cUDjQzwXYivU5g8MG_xGrzmDXZJROrGL5X8hKWyi1MiF4zhgOLLXGaAtiqwldUSnXlPSNU=\" rel=\"nofollow\" target=\"_blank\">REGISTER HERE<\/a><br \/><strong>Available for 1&#215;1 meetings:<\/strong> September 16-26th. Sign up <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7_8akRNHBA91KyLwWX9x_0_eVYc1LAvNEhMPFuFOZJB6j_rMR-EgKu6XexONDbiy-BTXrik_D5yPjqxBiLoxyO5hc82gfg2QNYYA5H9h3Ck76SraUJ6zWGadvu5C-qTOXV8uEcCXQszQdRm8oelkqDyhZ8olRCpBSxBypAAe7AVTml8KvomQfP_N-zSHKaaidOKFdDqCFx5-aqb2YdTyP3kWVE3hYU5kd1TPq4phizyhgrTnNR8yObr3L8f3HhC6kX7EC-hJLUJD4waLsMWoA==\" rel=\"nofollow\" target=\"_blank\">here<\/a><\/p>\n<p align=\"justify\">This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.<\/p>\n<p align=\"justify\">It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.<\/p>\n<p align=\"justify\">Learn more about the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QbIkbE5L3-3FLPdLFnfw0WMwuz-1kOXduXa0ANWvt4DVG7kQYJPxaLmcHW6AxfAxLJ3dQK7EL4qrJzGcG99GFrU0mqDLmCfIJHFOVT-SpInkC-IQGxBLY5sM_2OoceWpGqgcLlk_IIQrVKSGybpWLg==\" rel=\"nofollow\" target=\"_blank\"><u>www.virtualinvestorconferences.com<\/u><\/a><u>.<\/u><\/p>\n<p align=\"justify\">\n        <strong>Recent Company Highlights<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Dermata recently announced a strategic pivot to over-the-counter skin care treatments<\/li>\n<li style=\"text-align:justify\">The pivot is designed to address a growing demand for high-quality, scientifically proven OTC products<\/li>\n<li style=\"text-align:justify\">The Company plans to launch its once-weekly OTC acne kit in the middle of 2026 which it believes is highly differentiated from current acne treatments<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Virtual Investor Conferences<sup>\u00ae<\/sup><\/strong><br \/>\n        <br \/>Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.<\/p>\n<p align=\"justify\">Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking <\/strong><br \/>\n        <strong>Statements<br \/><\/strong>Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are based on the Company&#8217;s current beliefs and expectations and new risks may emerge from time to time. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors including, but are not limited to, statements related to: Dermata\u2019s shift to prioritize OTC dermatology products; the anticipated benefits of the strategic shift; the anticipated benefits of Dermata\u2019s strategic shift, including acceleration of its path to commercialization, reduction of regulatory burdens, and expansion into broader consumer markets; the expected timing and success of any planned or future OTC product launches; and other factors described in the Company\u2019s filings with the Securities and Exchange Commission. These forward-looking statements are generally identified by the use of such words as \u201cmay,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201cbelieve,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201ccontinue,\u201d \u201coutlook,\u201d \u201cwill,\u201d \u201cpotential\u201d and similar statements of a future or forward-looking nature. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug development, approval and commercialization, and the fact that past results of clinical trials may not be indicative of future trial results. For a discussion of these and other factors, please refer to Dermata&#8217;s filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are qualified in their entirety by this cautionary statement and Dermata undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof, except as required by law.<\/p>\n<p align=\"justify\">\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Dermata Investors:<br \/><\/strong>Cliff Mastricola<br \/>Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fd2NqbLklV1Gv-YqTEunaSq62eNqD0pHhEEuys8_n92jIvac-x51LfgBkW2ij2Qf8h9_xiMN5xuEw7HFxXOE5RfTryF-_dKW0u6z6yEXGknswLnuZigkAtXsWRw1fK_E\" rel=\"nofollow\" target=\"_blank\">cmastricola@dermatarx.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Virtual Investor Conferences <\/strong><br \/>\n        <br \/>John M. Viglotti<br \/>SVP Corporate Services, Investor Access<br \/>OTC Markets Group <br \/>(212) 220-2221<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GIiG2zSKXEm2rdVozUgR48xrMo7l74n-UzYAzzxDh5cPBSD90TvFr8qFjyn3GsHPUMpz3VgHoMNUsYX17msqs9mjrcJVgNslipEpOZHR_fQ=\" rel=\"nofollow\" target=\"_blank\">johnv@otcmarkets.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDc0MDYyNzYtMzAzZi00MGFjLTk1OTQtMmE5ZDk2NTJiNTEyLTEyNDQ1OTQtMjAyNS0wOS0xNi1lbg==\/tiny\/Virtual-Investor-Conferences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) &#8212; Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com San Diego, CA,\u00a0September 16, 2025\u00a0&#8212;\u00a0Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (\u201cDermata\u201d or the \u201cCompany\u201d), a science-driven leader in dermatologic solutions, today announced\u00a0that Gerry Proehl, Founder and CEO of Dermata, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025. DATE: September 18thTIME: 11:30 AM ESTLINK:REGISTER HEREAvailable for 1&#215;1 meetings: September 16-26th. Sign up here This will be a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-886707","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) &#8212; Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com San Diego, CA,\u00a0September 16, 2025\u00a0&#8212;\u00a0Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (\u201cDermata\u201d or the \u201cCompany\u201d), a science-driven leader in dermatologic solutions, today announced\u00a0that Gerry Proehl, Founder and CEO of Dermata, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025. DATE: September 18thTIME: 11:30 AM ESTLINK:REGISTER HEREAvailable for 1&#215;1 meetings: September 16-26th. Sign up here This will be a &hellip; Continue reading &quot;Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T15:35:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th\",\"datePublished\":\"2025-09-16T15:35:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/\"},\"wordCount\":1350,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/\",\"name\":\"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=\",\"datePublished\":\"2025-09-16T15:35:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/","og_locale":"en_US","og_type":"article","og_title":"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Market Newsdesk","og_description":"Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) &#8212; Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com San Diego, CA,\u00a0September 16, 2025\u00a0&#8212;\u00a0Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (\u201cDermata\u201d or the \u201cCompany\u201d), a science-driven leader in dermatologic solutions, today announced\u00a0that Gerry Proehl, Founder and CEO of Dermata, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025. DATE: September 18thTIME: 11:30 AM ESTLINK:REGISTER HEREAvailable for 1&#215;1 meetings: September 16-26th. Sign up here This will be a &hellip; Continue reading \"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-16T15:35:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th","datePublished":"2025-09-16T15:35:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/"},"wordCount":1350,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/","name":"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=","datePublished":"2025-09-16T15:35:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyOTY3MiM3MTQ4NTk0IzIyMzMwNDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dermata-therapeutics-to-present-at-the-life-sciences-virtual-investor-forum-september-18th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/886707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=886707"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/886707\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=886707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=886707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=886707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}